Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-06-13

Clinical Trial Update: CIMT and taVNS for Hemiplegia in Infants [EARLY_Phase 1]

View source ↗

Summary

This EARLY Phase 1 trial assessed combining Constraint Induced Movement Therapy (CIMT) with transcutaneous auricular vagus nerve stimulation (taVNS) for infants…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Medical University of South Carolina | Conditions: Infant Development, Hemiplegia | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2025-06-13